Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Natalizumab: A Review of Its Use in the Management of Relapsing-Remitting Multiple Sclerosis.
Treatment of multiple sclerosis in Germany: an analysis based on claims data of more than 30,000 patients.
Multiple Autoimmune-Associated Variants Confer Decreased IL-2R Signaling in CD4(+)CD25(hi) T Cells of Type 1 Diabetic and Multiple Sclerosis Patients.
Multiple sclerosis and the role of immune cells.
A Bayesian approach to probabilistic sensitivity analysis in structured benefit-risk assessment.
Cortical relapses in multiple sclerosis.
Applications of optical coherence tomography in pediatric clinical neuroscience.
Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis.
Schwann cells and their transcriptional network: Evolution of key regulators of peripheral myelination.
Astrocyte matricellular proteins that control excitatory synaptogenesis are regulated by inflammatory cytokines and correlate with paralysis severity during experimental autoimmune encephalomyelitis.
Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review.
Relationship Between Botulinum Toxin, Spasticity, and Pain: a Survey of Patient Perception.
A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination.
[The experience of using fingolimod (gilenya) in patients with relapsing-remitting multiple sclerosis.]
Elevated CSF histamine levels in multiple sclerosis patients.
Mood disorder as the presenting manifestation of demyelination.
Fibronectin in tissue regeneration: timely disassembly of the scaffold is necessary to complete the build.
Peripheral (Seventh) Nerve Palsy and Multiple Sclerosis: A Diagnostic Dilemma - A Case Report.
Altered molecular expression of TLR-signaling pathways affects the steady-state release of IL-12p70 and IFN-α in patients with relapsing-remitting multiple sclerosis.
Laquinimod in the treatment of multiple sclerosis: a review of the data so far.
Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy.
Decreased concentration of Klotho in the cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.
Predictors of chronic cerebrospinal venous insufficiency procedure use among older people with multiple sclerosis: a national case-control study.
A case series of autoimmune diseases accompanied by incidentally diagnosed monoclonal gammopathy: Is there a link between the two diseases?
Ninjurin1 enhances the basal motility and transendothelial migration of immune cells by inducing protrusive membrane dynamics.
Pages
« first
‹ previous
…
601
602
603
604
605
606
607
608
609
…
next ›
last »